黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 上海復(fù)祥生物科技有限公司

          當(dāng)前位置:上海復(fù)祥生物科技有限公司>>細(xì)胞庫>>人腫瘤細(xì)胞、癌細(xì)胞>>U-937人組織細(xì)胞淋巴瘤細(xì)胞

          人組織細(xì)胞淋巴瘤細(xì)胞

          參   考   價: ¥ 1

          訂  貨  量: ≥1 件

          具體成交價以合同協(xié)議為準(zhǔn)

          產(chǎn)品型號:U-937

          品       牌:其他品牌

          廠商性質(zhì):生產(chǎn)商

          所  在  地:上海市

          更新時間:2024-11-12 21:04:26瀏覽次數(shù):1848

          聯(lián)系我時,請告知來自 化工儀器網(wǎng)
          供貨周期 一周 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
          主要用途 科學(xué)研究
          CRL-1593.2 U-937 人組織細(xì)胞淋巴瘤細(xì)胞,
          原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種;
          細(xì)胞庫管理規(guī)范,提供的細(xì)胞株背景清楚,
          提供參考文獻(xiàn)和培養(yǎng)條件!

          CRL-1593.2 U-937 人組織細(xì)胞淋巴瘤細(xì)胞

          ATCC® Number: CRL-1593.2™ Price:

          Designations: U-937

          Depositors: H Koren

          Biosafety Level: 1

          Shipped: frozen

          Medium & Serum: See Propagation

          Growth Properties: suspension

          Organism: Homo sapiens (human)

          Morphology: monocyte

          CRL-1593.2 U-937 人組織細(xì)胞淋巴瘤細(xì)胞

          Source: Disease: histiocytic lymphoma

          Cellular Products: lysozyme; beta-2-microglobulin (beta 2 microglobulin); tumor necrosis factor (TNF), also known as tumor necrosis factor alpha (TNF-alpha, TNF alpha), after stimulation with phorbol myristic acid (PMA)

          Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


          Restrictions: The original U-937 cell line was established by Dr. K. Nilsson's laboratory in 1974 and he has requested the following: (1) In all papers reporting any use of this cell line or any derivatives thereof a direct reference should be made to Sundstrom and Nilsson (Int. J. Cancer 17: 565-577, 1976). (2) Any proposed commercial use of the cells should be negotiated with Professor Kenneth Nilsson, Rudbeck Laboratory, SE-751 85 Uppsala, Sweden. (3) No distribution of any of the cells or sublines derived therefrom should be made to third parties; (4) The cells should be used for non-clinical, non-commercial research only.

          Isolation: Isolation date: 1974

          Applications: transfection host (Roche FuGENE® Transfection Reagents

          Nucleofection technology from Lonza)

          Receptors: complement (C3)

          DNA Profile (STR): Amelogenin: X

          CSF1PO: 12

          D13S317: 10,12

          D16S539: 12

          D5S818: 12

          D7S820: 9,11

          THO1: 9.3

          TPOX: 8,11

          vWA: 15

          Age: 37 years

          Gender: male

          Ethnicity: Caucasian

          Comments: The U-937 cell line was derived by Sundstrom and Nilsson in 1974 from malignant cells obtained from the pleural effusion of a patient with histiocytic lymphoma.

          Studies since 1979 have shown that U-937 cells can be induced to terminal monocytic differentiation by supernatants from human mixed lymphocyte cultures,

          phorbol esters, vitamin D3, gamma interferon, tumor necrosis factor (TNF) and, retinoic acid.

          The cells are negative for immunoglobulin production and Epstein-Barr virus expression.

          The cells express the Fas antigen, and are sensitive to TNF and anti-Fas antibodies.

          In 1994, PCR and cytogenetic analyses showed that a number of stocks of U-937 were contaminated with the human myeloid leukemia cell line, K-562.

          In the earliest stocks available, the level of contamination was 0.6%. [40484]

          Distribution was discontinued in March 1994, except if required for patent purposes.

          Anyone who wishes to receive a sample of this original material should contact the Head of the ATCC Patent Depository.

          A stock of CRL-1593 found to be free of K-562 was propagated continuously for 8 weeks and tested weekly by PCR.

          Distribution and seed stocks give DNA profiles characteristic of U-937 only.

          Such preparations are now offered as authentic U-937 (ATCC CRL-1593.2) and are believed to be free of second subpopulations.

          Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.

          Atmosphere: air, 95%; carbon dioxide (CO2), 5%

          Temperature: 37.0°C

          Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10(5) viable cells/ml.

          Interval: Maintain cell density between 1 X 10(5) and 2 X 10(6) viable cells/ml.

          Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density)

          Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

          Storage temperature: liquid nitrogen vapor phase

          Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

          recommended serum:ATCC 30-2020

          References: 1080: Ralph P, et al. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med. 143: 1528-1533, 1976. PubMed: 1083890

          21866: . Gene expression during normal and malignant differentiation. London: Academic Press; 1985.

          21876: . International symposium on new trends in human immunology and cancer immunotherapy. Paris: Doin Editeurs; 1980.

          22906: Koren HS, et al. In vitro activation of a human macrophage-like cell line. Nature 279: 328-331, 1979. PubMed: 450085

          22912: Gidlund M, et al. Natural killer cells kill tumour cells at a given stage of differentiation. Nature 292: 848-850, 1981. PubMed: 7266653

          23049: Olsson I, et al. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res. 43: 5862-5867, 1983. PubMed: 6315218

          23103: Morimoto H, et al. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 53: 2591-2596, 1993. PubMed: 7684321




          CRL-1593.2 U-937



















          BEL-7402 人肝癌細(xì)胞系

          BEL-7402 人肝癌細(xì)胞系 細(xì)胞|細(xì)胞系|細(xì)胞

          HTB-56 Calu-6 人

          HTB-56 Calu-6 人肺癌細(xì)胞系(未分化癌

          人結(jié)腸癌細(xì)胞系

          CCL-227 SW620 人結(jié)腸癌細(xì)胞系$r$n

          會員登錄

          X

          請輸入賬號

          請輸入密碼

          =

          請輸驗證碼

          收藏該商鋪

          X
          該信息已收藏!
          標(biāo)簽:
          保存成功

          (空格分隔,最多3個,單個標(biāo)簽最多10個字符)

          常用:

          提示

          X
          您的留言已提交成功!我們將在第一時間回復(fù)您~

          以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。

          溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。

          撥打電話
          在線留言
          水富县| 丰镇市| 上栗县| 沧源| 寿阳县| 都安| 台湾省| 定兴县| 同仁县| 揭东县| 正阳县| 庆城县| 抚远县| 黄骅市| 澎湖县| 射阳县| 呈贡县| 盖州市| 张家口市| 大渡口区| 鄂伦春自治旗| 庆城县| 麻阳| 察雅县| 淮滨县| 惠州市| 日土县| 安康市| 阜城县| 双城市| 墨竹工卡县| 郧西县| 房产| 许昌县| 巧家县| 社旗县| 绍兴县| 绥棱县| 新营市| 许昌市| 上高县|